NOS3 and endothelial dysfunction: Palmitoleic acid is a known marker of de novo lipogenesis, and it correlates to endothelial dysfunction since it is usually released to restore a compromised vascular functionality by improving the bioavailability of endothelial nitric oxide synthase (eNOS) [23].